FDA Investigator Wayne T Smith
Wayne T Smith has inspections in 8 countries as of 31 Aug 2023. Wayne T Smith has collaborated with a combinined 2778 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
20
Last Inspection Date:
31 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India,
China,
Italy,
Belgium,
Israel,
United States of America,
Netherlands,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alan P Kurtzberg,
Albert A Salvador,
Alicia M Mozzachio,
Allan P Kurtzberg,
Allen F Hall,
Amanda E Lewin, PhD,
Anastasia M Shields,
Ann L Demarco,
Ann Marie Montemurro,
Anna M Brannen,
Anthony A Charity,
Anthony C Warchut,
Barbara Janine Breithaupt,
Ben Du,
Bonita S Chester,
Brandy N Lepage,
Charles I Ann,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christina K Theodorou,
Christina Theodorou,
Christopher T Middendorf,
Concepcion Cruz, Jr,
Craig D Zagata,
Cynthia J Lee, MS,
Cynthia White,
Daniel J Grabicki,
Daniel T Lee,
David R Heiar,
Debra J Bennett,
Debra L Pagano,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Derek S Dealy,
Derek S Smith, PhD,
Dipesh K Shah,
Douglas A Campbell,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Elena Karnaukhova, PhD,
Eric M Mueller, PharmD,
Erika M Wilkerson,
Farhana Khan,
Felix Maldonado,
Frank W Perrella,
Gajendiran Mahadevan, PhD,
Gayle S Lawson,
George J Flynn,
Gerardo Z Vazquez,
Hala L Selby,
Hanisol Fabenelle,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James D Planchon,
Jeen S Min,
John S Hartford,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose R Hernandez,
Jose Velez,
Judith A Paterson,
Julianne C Mccullough,
Kara A Scheibner, PhD,
Karen E D'orazio,
Katherine E Jacobitz,
Katherine Szestypalow,
Kathryn A Krentz,
Kevin A Gonzalez,
Kham Phommachanh,
Kimberley A Hoefen,
Kirtida Patel,
Kristina J Donohue,
Latorie S Jones,
Laurie B Frazier,
Leonard H Lavi,
Linda Thai,
Lisa L Tung,
LTJG Bradley E Benasutti,
Luis M Burgos Medero,
Marc R Dickens,
Marcelo O Mangalindan, Jr,
Margaret A Smithers,
Margaret M Annes,
Maridalia Torres Irizarry,
Marie F Morin,
Marisol Faberlle,
Martha Sullivan Myrick,
Marvin D Jones,
Matthew B Casale,
Meena Bansal Gupta, PhD,
Michael D Omeara,
Michael S Araneta,
Mike M Rashti,
Mohsen Rajabi Abhari, FDA,
Mra Davism,
Mra M Barbosar,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Murthy Vkn Sikha,
Nadeem I Chaudhry,
Nicole K Trudel,
Norman K Starks,
Patrick L Wisor,
Paul L Bellamy,
Peter E Baker,
Pratik S Upadhyay, DDC,
Rafael E Arroyo,
Reba A Gates,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard E Needham,
Richard Heath Coats,
Robert D Tollefsen,
Robert J Maffei,
Robert J Martin,
Rochelle K Kimmel,
Roger F Zabinski,
Ruark Lanham,
Ruben C Ayala, PharmD,
Russell J Glapion,
Saied A Asbagh,
Sandra A Hughes,
Sherri N Rohlf, MD,
Sidney B Priesmeyer,
Simone E Pitts,
Steven C Madzo,
Steven L Carter,
Steven M Weinman,
Susan F Laska, MS,
Susan M Jackson,
Susanne M Richardson, MSc RAC ELS,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Teresa I Navas,
Terri L Dodds,
Thai D Truong,
Thomas J Arista,
Thomas R Withers,
Timothy T Kapsala,
Torrance J Slayton,
Uttaniti Limchumroon (Tom),
Vlada Matusovsky,
Walden H Lee,
Wayne E Seifert,
Yvesna C Blaise,
Zhongren Wu
Wayne T Smith's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2003 | EIR | MSD Organon - EIR, 2003-07-11 |
| October, 2001 | FDA 483 | Ortho-McNeil Pharmaceutical Inc - Form 483, 2001-10-05 |
| March, 2000 | FDA 483 Response | Sybron Chemical Div - Form 483R, 2000-04-19 |
| July, 2003 | FDA 483 Response | N.V. Organon - Form 483R, 2003-11-04 |
| March, 2004 | EIR | SICOR Societa' Italiana Corticosteroidi s.r.l. - EIR, 2004-04-14 |
| July, 2003 | EIR | N. V. Organon - EIR, 2003-07-18 |
| March, 2000 | FDA 483 | Sybron Chemical Div - Form 483, 2000-03-10 |
| March, 2006 | EIR | Novetide Ltd. - EIR, 2006-03-15 |
| March, 2000 | EIR | Sybron Chemical Div - EIR, 2000-03-10 |
| March, 2004 | EIR | Chemi SpA - EIR, 2004-05-04 |
| July, 2003 | EIR | N.V. Organon - EIR, 2003-07-17 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more